LeMaitre Vascular Return on Tangible Equity 2010-2024 | LMAT
Current and historical return on tangible equity values for LeMaitre Vascular (LMAT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| LeMaitre Vascular Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $0.04B | $0.23B | 19.64% |
| 2024-06-30 | $0.04B | $0.22B | 19.34% |
| 2024-03-31 | $0.03B | $0.20B | 18.26% |
| 2023-12-31 | $0.03B | $0.19B | 17.00% |
| 2023-09-30 | $0.03B | $0.18B | 16.67% |
| 2023-06-30 | $0.03B | $0.17B | 15.63% |
| 2023-03-31 | $0.02B | $0.16B | 13.82% |
| 2022-12-31 | $0.02B | $0.16B | 14.33% |
| 2022-09-30 | $0.02B | $0.15B | 14.87% |
| 2022-06-30 | $0.02B | $0.14B | 16.82% |
| 2022-03-31 | $0.03B | $0.14B | 23.03% |
| 2021-12-31 | $0.03B | $0.14B | 28.27% |
| 2021-09-30 | $0.03B | $0.13B | 37.97% |
| 2021-06-30 | $0.03B | $0.06B | 58.00% |
| 2021-03-31 | $0.03B | $0.05B | 62.89% |
| 2020-12-31 | $0.02B | $0.05B | 46.32% |
| 2020-09-30 | $0.02B | $0.03B | 35.56% |
| 2020-06-30 | $0.02B | $0.02B | 23.94% |
| 2020-03-31 | $0.02B | $0.09B | 20.22% |
| 2019-12-31 | $0.02B | $0.08B | 21.05% |
| 2019-09-30 | $0.02B | $0.09B | 21.92% |
| 2019-06-30 | $0.02B | $0.10B | 21.47% |
| 2019-03-31 | $0.02B | $0.09B | 26.36% |
| 2018-12-31 | $0.02B | $0.09B | 26.98% |
| 2018-09-30 | $0.02B | $0.08B | 25.30% |
| 2018-06-30 | $0.02B | $0.09B | 27.16% |
| 2018-03-31 | $0.02B | $0.08B | 24.00% |
| 2017-12-31 | $0.02B | $0.08B | 24.64% |
| 2017-09-30 | $0.02B | $0.07B | 25.40% |
| 2017-06-30 | $0.01B | $0.07B | 23.24% |
| 2017-03-31 | $0.01B | $0.06B | 20.60% |
| 2016-12-31 | $0.01B | $0.05B | 19.05% |
| 2016-09-30 | $0.01B | $0.06B | 19.05% |
| 2016-06-30 | $0.01B | $0.06B | 18.35% |
| 2016-03-31 | $0.01B | $0.06B | 17.48% |
| 2015-12-31 | $0.01B | $0.05B | 16.49% |
| 2015-09-30 | $0.01B | $0.05B | 15.22% |
| 2015-06-30 | $0.01B | $0.05B | 13.64% |
| 2015-03-31 | $0.01B | $0.04B | 11.24% |
| 2014-12-31 | $0.00B | $0.04B | 9.47% |
| 2014-09-30 | $0.00B | $0.04B | 7.50% |
| 2014-06-30 | $0.00B | $0.05B | 7.89% |
| 2014-03-31 | $0.00B | $0.04B | 8.57% |
| 2013-12-31 | $0.00B | $0.04B | 11.43% |
| 2013-09-30 | $0.00B | $0.03B | 11.51% |
| 2013-06-30 | $0.00B | $0.04B | 11.19% |
| 2013-03-31 | $0.00B | $0.04B | 11.11% |
| 2012-12-31 | $0.00B | $0.03B | 8.22% |
| 2012-09-30 | $0.00B | $0.04B | 5.37% |
| 2012-06-30 | $0.00B | $0.04B | 5.41% |
| 2012-03-31 | $0.00B | $0.04B | 5.41% |
| 2011-12-31 | $0.00B | $0.04B | 5.41% |
| 2011-09-30 | $0.00B | $0.04B | 10.81% |
| 2011-06-30 | $0.01B | $0.04B | 13.42% |
| 2011-03-31 | $0.01B | $0.04B | 16.33% |
| 2010-12-31 | $0.01B | $0.04B | 19.44% |
| 2010-09-30 | $0.01B | $0.04B | 17.02% |
| 2010-06-30 | $0.01B | $0.04B | 14.71% |
| 2010-03-31 | $0.00B | $0.03B | 12.12% |
| 2009-12-31 | $0.00B | $0.03B | 3.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.332B | $0.193B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |